12/10/2018 18:00:00

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMPE, OPK and HTHT

NEW YORK, Oct. 12, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.        

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE)

Class Period: December 14, 2017 to August 7, 2018

Lead Plaintiff Deadline: October 24, 2018

The lawsuit alleges Ampio Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) the FDA would find Ampio's AP-003-C Phase 3 clinical trial inadequate and not well-controlled; (2) as a result, Ampio had not successfully completed two pivotal clinical trials for Ampio; (3) consequently, Defendants' public statements were materially false and misleading at all relevant times.

Get additional information about the AMPE lawsuit: https://www.kleinstocklaw.com/pslra-1/ampio-pharmaceuticals-inc-loss-form?wire=3 

OPKO Health Inc. (NASDAQ: OPK)

Class Period: September 26, 2013 to September 7, 2018

Lead Plaintiff Deadline: November 13, 2018

The lawsuit alleges that throughout the class period, OPKO Health Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) OPKO and its Chairman and Chief Executive Officer, Phillip Frost, were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) this illicit scheme would result in governmental scrutiny including from the SEC; and (3) as a result, defendants’ statements about OPKO’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the OPK lawsuit: https://www.kleinstocklaw.com/pslra-1/opko-health-inc-loss-submission-form?wire=3 

Huazhu Group Limited (NASDAQ: HTHT)

Class Period: May 14, 2018 to August 28, 2018

Lead Plaintiff Deadline: December 7, 2018

Throughout the class period, Huazhu Group Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate security measures to protect customer information; (2) as a result of the foregoing, the Company would be susceptible to increased litigation risk and higher expenses; (3) as a result of the foregoing, the Company’s goodwill would potentially suffer, leading to lower revenues; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

Get additional information about the HTHT lawsuit: https://www.kleinstocklaw.com/pslra-1/huazhu-group-limited-loss-submission-form?wire=3 

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Joseph Klein, Esq.

Empire State Building

350 Fifth Avenue

59th Floor

New York, NY 10118

jk@kleinstocklaw.com

Telephone: (212) 616-4899

Fax: (347) 558-9665

www.kleinstocklaw.com 

Klein NEW logo black transparent.png

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
07 Dec
VELO
Nedenfor vil jeg give et overblik over hvorfor jer er aktionær. Jeg tager måske fejl med mine antage..
38
07 Dec
VELO
CANADA godkendelse (ENDO)   Jeg lovede i en tråd for 2 uger siden at undersøge hvornår vi kan forven..
36
06 Dec
SAS-DKK
SAS aktien har fået kursklø efter et flot og fornemt regnskab, ledelsen vil ikke give budget for reg..
32
08 Dec
VELO
Havde igår en lang snak med min kapitalforvalter emnet - hvordan er det gået Hr og Fru Danmark's por..
27
10 Dec
VELO
Når man følger Veloxis-debatten, og det hr jeg gjort i mange, mange år - også da den hed LCP, så går..
17
06 Dec
VELO
  Man kan ikke være i tvivl om formålet med nyt afsnit, samt formuleringen i overskriften, når man s..
16
10 Dec
I:DAX
Det der foregår har da absolut intet med et flash crash at gøre ! Lad dog være med at brug fine bete..
15
10 Dec
 
Klart, klart... et firma, der reklamerer må være desperat. Personligt synes jeg ikke Pandora har n..
15
05 Dec
DANSKE
Danske bank er ikke mere kriminel end en politibetjent der ikke anholder en butikstyv.
14
06 Dec
 
Dette er hvad jeg kan læse, inden betalingsmuren sænker sig: Berlingske Media skruer op for ambition..
13

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinson’s Disease
2
Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea
3
Uptick Newswire’s Stock Day Podcast Hosts Medifocus, Inc.’s CEO to Discuss Their Minimally Invasive Breakthrough Treatments for Prostate and Breast Cancers
4
WISeKey Secures Printer Systems, from Cartridge to Cloud, with WISePrint@Cloud
5
Flame Seal Products FS-PG Wildfire Protection System Proves Totally Effective in Raging California Wildfire

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
11 December 2018 03:13:25
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181207.1 - EUROWEB1 - 2018-12-11 04:13:25 - 2018-12-11 03:13:25 - 1000 - Website: OKAY